Thursday, July 3, 2025 7/3/2025

Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity

Award Number: R01CA287076
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/04/2024
PERIOD OF PERFORMANCE END DATE: 03/31/2029

Group Awards By:

View Award Description

Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity - Cancer immunotherapy using checkpoint blockade (CPB) has revolutionized cancer treatment, providing durable cures with acceptable toxicity in some cancer patients. However, only a few cancer types respond and even in responding tumor types, response is often limited to a minority of these cancers, which raises the question whether directly targeting T cells is sufficient and whether other aspects of immunity can be exploited to stimulate or boost antitumor immunity. Inflammatory, or immunogenic, cell death is emerging to be an important immune node that bridges innate and adaptive immunity to stimulate antitumor immunity as well as to potentiate CPB. While antineoplastic agents currently used in humans can also sometimes induce inflammatory cell death to help re-establish immune surveillance in the tumor microenvironment, these agents do not predictably induce immunogenic cell death, thus leading to variable outcomes. The hypothesis we propose in this project can fundamentally change this scenario by inducing predictable immunogenic cell death through targeting key molecules known as gasdermins (GSDMs) in particular GSDMD, which are widely expressed in cancers and can directly induce immunogenic cell death upon activation. GSDMD mediates pyroptosis and cytokine release downstream of inflammasomes, which are supramolecular complexes that activate inflammatory caspases (caspase-1/-4/-5 in humans, caspase-1/-11 in mice). Activated caspase-1 processes IL-1 family cytokines to their active forms and all inflammatory caspases cleave GSDMD to produce an N-terminal (NT) fragment that forms pores in the cell membrane to induce pyroptosis, and to release IL-1 family cytokines and other inflammatory mediators, including ATP and HMGB1. We specifically propose to identify small molecule agonists of GSDMD for direct induction of immunogenic pyroptosis in cancer cells, which may also synergize with other immune modulators as well as with CPB. GSDMD is widely expressed in cancers. While GSDMD is also expressed in some normal tissues, the need for only a small fraction of tumor cells to undergo pyroptosis to alert the immune system may make GSDMD agonism non-toxic even when administered systemically.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $733,069 )
2025	2025	CHILDREN'S HOSPITAL CORPORATION, THE	300 LONGWOOD AVE	BOSTON	MA	02115	SUFFOLK	USA	Cancer Treatment Research	001	2	5/22/2025	NON-COMPETING CONTINUATION	$73,306
2025	2025	CHILDREN'S HOSPITAL CORPORATION, THE	300 LONGWOOD AVE	BOSTON	MA	02115	SUFFOLK	USA	Cancer Treatment Research	000	2	3/3/2025	NON-COMPETING CONTINUATION	$659,763
														Subtotal = $733,069

Issue Date FY: 2024 ( Subtotal = $733,069 )
2024	2024	CHILDREN'S HOSPITAL CORPORATION, THE	300 LONGWOOD AVE	BOSTON	MA	02115	SUFFOLK	USA	Cancer Treatment Research	000	1	4/4/2024	NEW	$733,069
														Subtotal = $733,069

Grand Total All Awards = $1,466,138

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity

Award Number: R01CA287076

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/04/2024

PERIOD OF PERFORMANCE END DATE: 03/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer